Sanorin drops Nazal. emulsion 10ml vial of 0.1% eucalyptus oil

$3.73

Sanorin drops Nazal. emulsion 10ml vial of 0.1% eucalyptus oil

Quantity:

SKU: 589653965 Categories: , , Tags: ,

Description

Composition
Active substance:
10 ml of the preparation contains: active substance: naphazoline nitrate 0.010 g ;.
Excipients:
Boric acid 0.300 g ethylenediamine q.s. (About 0.0004 g), 0.004 g of cetyl alcohol, methylparaben About 0.01 g, 0.00025 g of eucalyptus oil, polysorbate 80, 0.055 g, 0.008 g of cholesterol, liquid paraffin (vaseline oil) 1.150 g purified water and 10,000 ml .
Description:
White homogenous emulsion.
Product form:
Nasal drops 0.1%.
10 ml of the product into vials of brown glass equipped with kapennitsey SANO with polyethylene cap security tamper-evident tape and label originals. Each vial is placed in a cardboard box with instructions for use.
Contraindications
Hypersensitivity to naphazoline or one component of the drug; age under 15 years; atherosclerosis; arteriapnaya hypertension; tachycardia; hyperthyroidism; chronic atrophic rhinitis; severe eye disease; closure glaucoma; diabetes; simultaneous reception of monoamine oxidase inhibitors (MAO) and up to 14 days after the end of application.
Carefully
Pregnancy, lactation, ischemic heart disease (including angina), prostatic hyperplasia, pheochromocytoma.
Dosage
1 mg / ml
Indications
• reduction of the edema of the mucous membranes of the nose, including acute rhinitis with various etiologies, sinusitis, laryngitis, eustachian, otitis media (as an additional means); • to reduce the swelling of the nasal mucous membranes, nasal sinuses and in diagnostic and therapeutic procedures.
Interaction with other drugs
With simultaneous application of naphazoline with MAO inhibitors, tricyclic antidepressants, including maprotiline, and even a few days after their application possibly increased blood pressure, which is due to the release of catecholamines deposited under naphazoline.
In general anesthesia with anesthetic agents that increase the sensitivity of the myocardium to sympathomimetics (halothane), especially in patients with bronchial asthma with caution.
Overdose
Symptoms: irritability, headache, tremor, palpitations, tachycardia, and increased blood pressure. Symptoms of overdose may be nausea, cyanosis, fever, convulsions, acute heart failure, pulmonary edema, respiratory failure, mental disorders, bradycardia, weakness, drowsiness, decreased body temperature, increased sweating, decreased blood pressure, rarely coma may develop.
Treatment: symptomatic.
pharmachologic effect
Pharmacological group:
Decongestant agent alpha-agonists.
Pharmacodynamics:
Pharmacodynamics:
Naphazoline relates to alfa2- adrainomimetiki direct stimulating effect on alpha-adrenergic receptors of the sympathetic nervous system. Intranasal administration provides a rapid, pronounced and prolonged vasoconstriction action against vascular nasal mucous membranes, nasal and paranasal sinuses – reduces swelling and congestion, thereby improving the permeability of the nasal passages and nasal breathing is facilitated. The therapeutic effect occurs, usually within 5 min after injection and lasts for 4-6 hours.
Pharmacokinetics:
Information concerning the distribution, metabolism and elimination nafazolina person does not have.
Pregnancy and breast-feeding
No data on the penetration nafazolina through the placental barrier and into breast milk.
In this regard, the appointment of nafazolina need to weigh the benefits to the mother and the risk to the fetus and infant.
Conditions of supply of pharmacies
Without recipe.
side effects
The recommended doses are usually naphazoline horoshoperenositsya.
The respiratory system: dry nose, reactive hyperemia nasal mucous membrane, irritation and swelling of the nasal mucosa when applied longer than 1 week, atrophic rhinitis.
From the nervous system: irritability, headache, tremor.
Cardio-vascular system: increased blood pressure (BP), “tides”, and tachycardia.
Other: increased sweating.
special instructions
Patients receiving high doses of naphazoline, require careful monitoring because of the possible development of undesired side reactions of the cardiovascular system and the nervous system (see. The section “Side effect”).
Use of the drug over 5 days can lead to swelling and edema of the nasal mucosa, nasal sinuses and nasopharynx. Long term use of the drug leads to damage to the mucous membrane, decrease of the ciliary activity and irreversible damage leading to occurrence of chronic atrophic rhinitis.
Effects on ability to drive vehicles, machinery
At the recommended dose of the drug does not affect the ability to drive vehicles and management mechanisms.
Storage conditions
Store at a temperature of from 10 ° C to 25 ° C in a dark place.
Keep out of the reach of children.
Dosing and Administration
Adults and children over 15 years
Intranasally. 1-3 drops of the drug in each nostril 3-4 times a day. Duration of treatment no more than 5-7 days. If necessary, treatment can be resumed in a few days. The drug is instilled into each nostril with the little head thrown back. When backfilling in pevy nostril head should be tilted to the right, and when instilled into the right nasal hod- left.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Sanorin

There are no reviews yet.

Add your review